Syntal Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,746
Closed -$738K 18
2023
Q3
$738K Sell
2,746
-2,397
-47% -$598K 0.57% 31
2023
Q2
$1.14M Sell
5,143
-344
-6% -$79.8K 0.46% 68
2023
Q1
$1.33M Buy
5,487
+1,013
+23% +$249K 0.49% 57
2022
Q4
$1.18M Sell
4,474
-307
-6% -$82.3K 0.47% 61
2022
Q3
$1.08M Buy
4,781
+47
+1% +$11.4K 0.44% 45
2022
Q2
$1.15M Sell
4,734
-97
-2% -$23.8K 0.51% 41
2022
Q1
$1.17M Buy
+4,831
New +$1.11M 0.46% 61
2021
Q3
Sell
-4,422
Closed -$1.08M 100
2021
Q2
$1.08M Buy
+4,422
New +$1.09M 0.38% 80
2021
Q1
Sell
-4,365
Closed -$1K 120
2020
Q4
$1K Sell
4,365
-1,815
-29% -$418K 0.13% 81
2020
Q3
$1.57M Buy
6,180
+1,694
+38% +$420K 0.71% 31
2020
Q2
$1.06M Buy
+4,486
New +$1.02M 0.5% 64
2019
Q4
Sell
-3,532
Closed -$651K 104
2019
Q3
$651K Hold
3,532
0.17% 110
2019
Q2
$651K Buy
+3,532
New +$632K 0.14% 135
2018
Q4
Sell
-1,206
Closed -$250K 95
2018
Q3
$250K Sell
1,206
-5
-0.4% -$985 0.09% 133
2018
Q2
$223K Buy
1,211
+1
+0.1% +$177 0.08% 126
2018
Q1
$206K Buy
1,210
+2
+0.2% +$367 0.07% 133
2017
Q4
$210K Buy
+1,208
New +$214K 0.06% 148
2015
Q4
Sell
-200
Closed -$27K 75
2015
Q3
$27K Hold
200
0.04% 100
2015
Q2
$30 Hold
200
0.03% 116
2015
Q1
$31K Hold
200
0.04% 116
2014
Q4
$31K Hold
200
0.02% 135
2014
Q3
$28K Hold
200
0.01% 143
2014
Q2
$23K Buy
+200
New +$23.2K 0.01% 166

Other funds holding AMGN

Syntal Capital Partners's AMGN Position: Q4 2023 in Review

Syntal Capital Partners sold out of Amgen (AMGN) in Q4 2023, closing a stake of 2,746 shares — an estimated $738K sold.

Syntal Capital Partners first reported a position in AMGN in Q2 2014 and held it in 23 quarters. The position peaked at $1.57M in Q3 2020. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Syntal Capital Partners reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Syntal Capital Partners sold 2,746 Amgen shares in Q4 2023, an estimated $738K.
  • Syntal Capital Partners first reported a position in Amgen in Q2 2014 and held it in 23 quarters.
  • Syntal Capital Partners's Amgen position peaked at $1.57M in Q3 2020.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Syntal Capital Partners's 13F filing for Q4 2023, filed 13 Feb 2024.